BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 29779853)

  • 1. The tsunami named CRISPR/Cas9.
    Chneiweiss H
    Rev Neurol (Paris); 2018; 174(7-8):487-488. PubMed ID: 29779853
    [No Abstract]   [Full Text] [Related]  

  • 2. Editor's comment on "CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein".
    Hohmann S
    Mol Genet Genomics; 2017 Jun; 292(3):535-536. PubMed ID: 28251316
    [No Abstract]   [Full Text] [Related]  

  • 3. Huntington disease: Selective deactivation of Huntington disease mutant allele by CRISPR-Cas9 gene editing.
    Malkki H
    Nat Rev Neurol; 2016 Nov; 12(11):614-615. PubMed ID: 27686048
    [No Abstract]   [Full Text] [Related]  

  • 4. [CRISPR-Cas9, germinal cells and human embryo].
    Jouannet P
    Biol Aujourdhui; 2017; 211(3):207-213. PubMed ID: 29412130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The CRISPR-Cas system: beyond genome editing].
    Croteau FR; Rousseau GM; Moineau S
    Med Sci (Paris); 2018 Oct; 34(10):813-819. PubMed ID: 30451675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9 gene-editing: Research technologies, clinical applications and ethical considerations.
    Memi F; Ntokou A; Papangeli I
    Semin Perinatol; 2018 Dec; 42(8):487-500. PubMed ID: 30482590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the potential of genome editing CRISPR-Cas9 technology.
    Singh V; Braddick D; Dhar PK
    Gene; 2017 Jan; 599():1-18. PubMed ID: 27836667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addressing challenges in the clinical applications associated with CRISPR/Cas9 technology and ethical questions to prevent its misuse.
    Kang XJ; Caparas CIN; Soh BS; Fan Y
    Protein Cell; 2017 Nov; 8(11):791-795. PubMed ID: 28986765
    [No Abstract]   [Full Text] [Related]  

  • 9. CRISPR takes on Huntington's disease.
    Eisenstein M
    Nature; 2018 May; 557(7707):S42-S43. PubMed ID: 29844549
    [No Abstract]   [Full Text] [Related]  

  • 10. CRISPR: History and perspectives to the future.
    Kozovska Z; Rajcaniova S; Munteanu P; Dzacovska S; Demkova L
    Biomed Pharmacother; 2021 Sep; 141():111917. PubMed ID: 34328110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of combined viral transduction and CRISPR/Cas9 gene editing in treating neurodegenerative diseases.
    Kuruvilla J; Sasmita AO; Ling APK
    Neurol Sci; 2018 Nov; 39(11):1827-1835. PubMed ID: 30076486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Counterpoint: The Potential Harms of Human Gene Editing Using CRISPR-Cas9.
    Baylis F
    Clin Chem; 2018 Mar; 64(3):489-491. PubMed ID: 29490999
    [No Abstract]   [Full Text] [Related]  

  • 13. Finding a Treatment for ALS - Will Gene Editing Cut It?
    Al-Chalabi A; Brown RH
    N Engl J Med; 2018 Apr; 378(15):1454-1456. PubMed ID: 29641956
    [No Abstract]   [Full Text] [Related]  

  • 14. Introducing precise genetic modifications into human 3PN embryos by CRISPR/Cas-mediated genome editing.
    Kang X; He W; Huang Y; Yu Q; Chen Y; Gao X; Sun X; Fan Y
    J Assist Reprod Genet; 2016 May; 33(5):581-588. PubMed ID: 27052831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New gene editing technique CRISPR-Cas9 raises important ethical questions, says advisory body.
    Hawkes N
    BMJ; 2016 Sep; 354():i5318. PubMed ID: 27694221
    [No Abstract]   [Full Text] [Related]  

  • 16. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
    Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
    Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The Washington summit: orange light for genome editing?].
    Jordan B
    Med Sci (Paris); 2016 Feb; 32(2):217-20. PubMed ID: 26936181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards a CRISPR view of early human development: applications, limitations and ethical concerns of genome editing in human embryos.
    Plaza Reyes A; Lanner F
    Development; 2017 Jan; 144(1):3-7. PubMed ID: 28049687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene editing in human development: ethical concerns and practical applications.
    Rossant J
    Development; 2018 Jul; 145(16):. PubMed ID: 30045910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas9 system: a powerful technology for in vivo and ex vivo gene therapy.
    Zhang X; Wang L; Liu M; Li D
    Sci China Life Sci; 2017 May; 60(5):468-475. PubMed ID: 28534255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.